Regulatory update: The Saudi government has notified registered users of the goverment's drug track and trace system (RSD) that the deadline for aggregation of medicines is now August 20, 2020.

How are pharma manufacturers expected to meet Saudi reporting requirements even as guidance from the Saudi Food and Drug Authority (SFDA) continues to evolve? Will aggregation events need to be reported to the Saudi government? How does the package Transfer System (PTS) affect your compliance planning?

Get the answers to these questions and more from TraceLink experts:

Video 1: Preparing for Saudi Arabia Compliance Reporting
TraceLink SVP of Product Marketing, Lucy Deus, provides an in-depth review of the January 2019 Saudi reporting requirements and the Saudi reporting system.

Video 2: Understanding October 2019 Saudi Arabia Aggregation Requirements
Lucy Deus explains the October 2019 Saudi aggregation requirements and how aggregation data will need to be exchanged with downstream trade partners.

Video 3: Leveraging Your Global Compliance Strategy in Saudi Arabia
TraceLink VP of Industry Marketing, Brian Daleiden, explains the importance of maintaining visibility into your Saudi supply chain by making it part of a global compliance strategy.